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A total of 105 patients with post-traumatic stress disorder (PTSD)were
randomly allocated to eye-movement desensitization and reprocessing
(EMDR) .n = 39/ versus exposure plus cognitive restructuring (EY
CR) (n = 37) versus waiting list (WL) (n = 29) in a primary care
setting. EMDR and EY CR patients received a maximum of 10
treatment sessions over a 10-week period. All patients were assessed
by blind raters prior to randomization and at end of the 10-week
treatment or waiting list period. EMDR and EY CR patients were
also assessed by therapists at the mid-point of the 10-week treatment
period and on average at 15 months follow-up. Patients were assessed
on a variety of assessor-rated and self-report measures of PTSD
symptomatology including the Clinician Administered PTSD Scale
(CAPS), the Impact of Events Scale (IOE) and a self-report version of
the SI-PTSD Checklist. Measures of anxiety and depression included
the Montgomery Asberg Depression Rating Scale (MADRS), the
Hamilton Anxiety Scale (HAM-A) and the Hospital Anxiety and
Depression Scale (HADS). A measure of social function, the Sheehan
Disability Scale was also used. Drop-out rates between the three
groups were 12 EMDR, 16 EY CR and five WL. Treatment end-point
analyses were conducted on the remaining 72 patients. Repeated
measures analysis of variance of treatment outcome at 10 weeks
revealed significant time, interaction and group effects for all the
above measures. In general there were significant and substantial
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pre–post reductions for EMDR and EY CR groups but no change
for the WL patients. Both treatments were effective over WL. The
only indication of superiority of either active treatment, in relation to
measures of clinically significant change, was a greater reduction
in patient self-reported depression ratings and improved social
functioning for EMDR in comparison to EY CR at the end of the
treatment period and for fewer number of treatment sessions for
EMDR (mean 4.2) than EY CR (mean 6.4) patients. At 15 months
follow-up treatment gains were generally well-maintained with the
only difference, in favour of EMDR over EY CR, occurring in relation
to assessor-rated levels of clinically significant change in depression.
However, exclusion of patients who had subsequent treatment
during the follow-up period diminished the proportion of patients
achieving long-term clinically significant change. In summary, at end
of treatment and at follow-up, both EMDR and EY CR are effective
in the treatment of PTSD with only a slight advantage in favour of
EMDR. Copyright  2002 John Wiley & Sons, Ltd.
INTRODUCTION
Post-traumatic stress disorder (PTSD) was first rec-
ognized in official psychiatric nosology in the third
edition of the Diagnostic and Statistical Manual of
Mental Disorders (DSM III) (American Psychiatric
Association, 1980). In DSM IV (American Psy-
chiatric Association, 1994) PTSD remains within
the anxiety disorders and may only be diag-
nosed following exposure to a traumatic event
in which (a) the person experienced, witnessed or
was confronted with an event that involved actual
or perceived threat to life or physical integrity
of self or others; and (b) the person’s response
to such event(s) involved intense fear, helpless-
ness or horror.
PTSD symptoms fall into three main group-
ings: (a) re-experiencing the trauma via intrusive
thoughts, images and dreams and intense distress
when faced with real or symbolic reminders of the
trauma; (b) persistent avoidance of stimuli asso-
ciated with the trauma and emotional numbing;
(c) symptoms of increased arousal such as sleep
disturbance, irritability, anger and hypervigilance.
Most of the epidemiological studies of the inci-
dence and prevalence of PTSD have been conducted
in the United States and have produced a wide
range of results. Helzer, Robins and McEvoy (1987)
report that approximately 1–2% of the US popula-
tion meet the criteria for PTSD. However, Kessler,
Sonnega, Bromet, Hughes, and Nelson (1995) cite
general population lifetime rates of up to 7.8%.
Comparable rates among specific trauma groups
are considerably higher, for example, 30% in Viet-
nam veterans and 32% in female rape victims
(Resnick, Kilpatrick, Dansky, Saunders, & Best
1993).
Cognitive-behavioural interventions, such as
exposure procedures, cognitive restructuring tech-
niques and anxiety management training are
among the most extensively investigated treat-
ments for anxiety disorders. The common feature
of exposure procedures is a confrontation of the
feared stimuli. These procedures may vary accord-
ing to the medium of exposure (imaginal versus in
vivo), length of exposure (short versus long) and
arousal level during exposure (low versus high)
(Foa, Rothbaum, & Kozak, 1989). With regard to
PTSD, a number of studies have attested to the effi-
cacy of imaginal and in vivo exposure techniques
(Richards, Lovell, & Marks, 1994; Thompson, Charl-
ton, Kerry, Lee, & Turner, 1995) while others
have illustrated comparative efficacy in relation
to supportive counselling (Foa, Rothbaum, Riggs,
& Murdock, 1991), and relaxation (Marks, Lovell,
Noshirvani, Livanou, & Thrasher, 1998). Trauma
desensitization, hypnotherapy and brief psycho-
dynamic therapy have been shown to be equally
effective and superior to waiting list (Brom, Kleber,
& Defares, 1989). Studies which have produced
more equivocal results regarding the efficacy of
exposure techniques in the treatment of PTSD have
invariably been confounded by the inclusion of
additional ‘standard treatment’ between compara-
tive groups. For example in comparisons of ‘direct
therapeutic exposure’ versus ‘conventional therapy
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or counselling’ among inpatient Vietnam veter-
ans all subjects appeared to receive ‘regular unit
milieu treatment’ which also included many ele-
ments of ‘direct therapeutic exposure’ (Boudewyns
& Hyer, 1990; Boudewyns, Hyer, Woods, Harrison,
& McCranie, 1990).
Similarly, comparisons of ‘standard treatment’
with or without imaginal flooding have produced
equivocal results probably due to the large variety
of confounding treatments offered under stan-
dard care (Cooper & Clum, 1989; Keane, Fairbank,
Cadell, & Zimering, 1989). It therefore appears
that in the case of exposure treatments for PTSD
equivocal results are associated primarily with con-
taminated treatment designs while well-controlled
studies indicate clear superiority of exposure-
based approaches.
A relatively new form of treatment for PTSD has
been proposed by Shapiro (1995) entitled Eye Move-
ment Desensitization and Reprocessing (EMDR). In
brief, the EMDR procedure requires the patient to
focus upon a disturbing image or memory and
related cognitions and emotions, while the thera-
pist induces bilateral stimulation either by visual
tracking, auditory stimulus or tactile stimulation.
Shapiro (2001) now regards dual attention stimu-
lation as possibly providing the most useful expla-
nation of EMDR’s accelerated effects. There has
been considerable debate concerning the theoreti-
cal basis of EMDR (e.g. Hassard, 1996; McCulloch
and Feldman 1990) and disagreement as to its effi-
cacy (Poole, deJongh, & Spector, 1999; Rosen, Lohr,
McNally, & Herbert, 1998). In recent years there has
been an increase in the number of well-controlled
studies regarding the efficacy of EMDR. Some stud-
ies have concentrated on examining the role of
specific components of EMDR (Pitman et al., 1996;
Renfrey & Spates, 1994; Wilson, Silver, Covi, &
Foster, 1996). In these studies EMDR has been com-
pared with variants such as EMDR saccadic eye
movements induced by alternating flashing lights;
EMDR minus eye movements, i.e. eyes fixed; EMDR
minus eye movements but with alternating thumb
tapping. Renfrey and Spates (1994) and Pitman et al.
(1996) have reported that there is little difference in
outcome between standard versus modified EMDR
and therefore conclude that the eye movements are
not essential to treatment. Conversely, Wilson et al.
(1996) report that eye movements correlate with
changes in autonomic measures such as respiration
and galvanic skin response and consequently eye
movements are considered the source of a relax-
ation response. EMDR is therefore seen as effective
as it pairs ‘distress with an internally-generated
and ‘‘compelled’’ relaxation response’ in a manner
equivalent to reciprocal inhibition. (Wilson et al.,
1996, p. 227).
Other EMDR controlled studies have investigated
absolute efficacy by comparing EMDR versus no
treatment (i.e. either waiting list or delayed treat-
ment) (Grainger, Levin, Allen-Byrd, Doctor, & Lee,
1997; Rothbaum, 1995; Wilson, Becker, & Tinker,
1995). Each of these studies report EMDR to be more
effective than no treatment. Studies have investi-
gated the relative efficacy of EMDR in comparison
with other psychotherapy treatments. In terms of
treatment outcome there is evidence to suggest that
EMDR is superior to biofeedback (Carlson, Chem-
tob, Rusnak, Hedlund, & Muraoka, 1995; Silver,
Brooks, & Obenchain, 1995), non-directive active
listening (Scheck, Schaeffer & Gillelte, 1998), and
‘exposure control’ (i.e. EMDR with eyes closed)
(Boudewyns and Hyer 1996; Boudewyns, Stwertka,
Hyer, Albrecht, & Sperr, 1993; Shapiro, 1989). A
number of studies have incorporated a comparison
of EMDR with ‘standard care’, some of which report
superiority of EMDR (e.g. Carlson et al., 1998; Mar-
cus et al., 1997) while others report no difference
in clinical outcome between ‘standard care’ and
EMDR (Boudewyns et al., 1993; Jensen, 1994). One
controlled study has compared EMDR versus imag-
inal exposure (i.e. image habituation training), these
treatments are also being compared with applied
muscle relaxation and waiting list (Vaughan et al.,
1994). All three treatments showed equal levels of
improvement which were superior to waiting list,
albeit a trend for superiority of EMDR in most
measures, and there was a significant superior-
ity for EMDR with regard to intrusive memories.
More recently, Devilly and Spence (1999) compared
EMDR and a CBT variant entitled Trauma Treat-
ment Protocol (TTP). It was found that TTP was
more effective than EMDR but unfortunately a
waiting list control group was not included and
statistical analysis was carried out without control-
ling for very significant differences in expectancies
between the treatment groups.
In summarizing the controlled studies mentioned
above, it appears that many indicate a positive
outcome of EMDR in comparison with no treatment
or other forms of psychotherapy, while many other
studies indicate no difference between EMDR and
other treatments. This ambiguity is reflected in
recent reviews of this topic (Chambless et al., 1998;
Davidson & Parker, 2001; Van Etten and Taylor,
1998).
However, it is important to temper overall
conclusions with consideration of a number of
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methodological problems associated with certain
EMDR studies. With regard to treatment fidelity, a
small number of studies have probably incorrectly
applied EMDR by using untrained therapists. In
addition, only in some studies did all subjects
meet DSM PTSD criteria, in other studies only
a proportion of subjects met such criteria and
in the remainder diagnostic criteria were either
not provided or subjects were simply described
as having had a traumatic experience and/or
traumatic memories. In certain studies it is difficult
to ascertain exactly what was responsible for
change over treatment time. For example, with
regard to the use of concurrent psychotropics
during treatment, some studies openly permitted
this provided subjects were on a stable dosage,
other studies prohibited all psychotropics and the
remainder did not mention the issue of concomitant
psychotropics at all. With regard to non-study
concurrent psychotherapy, some studies permitted
this, other studies did not mention the issue, and
a few studies openly stated that this was not
permitted during the study period but did note that
such prohibition was not implemented between
end of study treatment and follow-up. With these
exceptions, the remainder of studies failed to take
account of post-study treatment (psychotherapy
and/or psychotropics) at time of follow-up. In
addition, some studies provided no follow-up and
in many the maximum length of follow-up was of
short duration (e.g. 1 month) with relatively few
studies providing long term follow-ups beyond 9
and 12 months.
One of the major problems in comparing such
studies is the variable amounts and type of treat-
ment offered, for example one session of EMDR
as used by Shapiro (1989) in comparison with
four sessions of EMDR used by Vaughan et al.
(1994). A further confound is the issue of EMDR
in comparison to ‘standard treatment’. Unfortu-
nately both between and within such studies
the content of ‘standard treatment’ varies con-
siderably, for example described as briefly as
‘milieu treatment’ by Boudewyns et al. (1993).
A more detailed description of ‘standard treat-
ment’ involved patients receiving ‘one or more
of the following: individual psychotherapy (cogni-
tive, psychodynamic, or behavioural); medication
(antidepressants, anti-anxiety medication); and/or
group therapy (relaxation training, panic and anx-
iety reduction, medication stabilization groups)’,
brief inpatient hospitalization and day-treatment
also having been used Marcus et al 1997, p. 309). In
many studies it is uncertain what EMDR is actually
being compared with.
A further problem is that EMDR has not been ade-
quately compared with exposure-based treatments
either imaginal or in vivo. As previously mentioned,
a number of studies have compared EMDR with an
‘exposure control’ for example EMDR with eyes
closed. Such an ‘exposure control’ is not equiva-
lent to image habituation training as practised by
Vaughan et al. (1994) in one of the few studies to
investigate imaginal exposure in comparison with
EMDR. Furthermore, there is a dearth of studies
that have investigated EMDR in comparison with
an exposure-based technique which incorporates
prolonged imaginal exposure, cognitive restructur-
ing, and where appropriate in vivo exposure as
utilized by Foa et al. (1991) and Marks et al. (1998).
The present study attempts to address some of
these issues in the treatment of PTSD by comparing
EMDR versus exposure plus cognitive restructur-
ing versus waiting list.
METHOD
Subjects
Outpatient referrals were taken from general prac-
titioners and psychiatrists within central Scotland.
Patients were considered suitable for study inclu-
sion if they met the following criteria: willing to
participate voluntarily and give written consent;
able to satisfy DSM IV criteria for PTSD; if on
medication, had been on a stable dose for at least
6 weeks, and were required to remain so for the
duration of the treatment trial; aged between 18 and
65 years. Patients were excluded if they exhibited
any of the following: concurrent severe depressive
illness; past or present psychotic illness; history of
alcoholism or drug abuse within the last 6 months
as defined by DSM IV; suicidal ideation or intent
as assessed at clinical interview; physical illness of
clinical significance; psychotherapy commitments
outwith the study.
Measures
Assessments pre- and post-treatment were con-
ducted by two independent assessors respectively,
who were blind to treatment conditions. Assess-
ments at mid-point of treatment and follow-
up were made by therapists who were not
blind to treatment conditions. In addition patients
Copyright  2002 John Wiley & Sons, Ltd. Clin. Psychol. Psychother. 9, 299–318 (2002)
Treatment of PTSD 303
completed a number of self-report measures, pre-,
mid- and post-treatment and at follow-up.
Assessor Measures
Frequency and intensity of individual symptoms
was assessed by the following measures:
(a) Clinician-Administered PTSD Scale (CAPS)
(Blake et al., 1990). This is comprised of 17 DSM
III-R PTSD symptoms each assessed accord-
ing to frequency and intensity over the past
week, each symptom rated on a 0–4 scale.
The 17 symptoms cluster into three subscales,
each rated in regard to frequency and intensity,
CAPS-B, Re-experience; CAPS-C, Avoidance;
CAPS-D, Arousal.
(b) Montgomery Asberg Depression Rating Scale
(MADRS) (Montgomery & Asberg, 1979). This
interviewer-rated scale assesses 10 symptoms
of depression each rated on a 0–6 scale.
(c) Hamilton Rating Scale for Anxiety (HAM-A)
(Hamilton, 1959). This scale incorporates 14
anxiety-related symptoms each rated 0–4.
Self-Report Measures
Patients completed a number of self report mea-
sures including:
(a) Impact of Events Scale (IOE) (Horowitz et al.,
1979). This comprises 15 questions each rated
on a 4-point scale and subdivided to provide
two ratings of intrusion and avoidance symp-
tomatology.
(b) A self-report version of the SI-PTSD Symp-
tom Checklist (Davidson, Smith, & Kudler,
1989). This comprises 12 self-rated questions
assessing the severity of DSM III-R symp-
toms each on a 0–4 scale. Three subscales
can be derived from this measure relating to
intrusive, avoidant and hyperarousal symp-
toms of PTSD.
(c) The Hospital Anxiety and Depression Scale
(HADS) (Zigmond & Snaith, 1983). This 14-item
measure assesses the presence and frequency of
symptoms each on a 4-point scale and provides
two subscale scores for anxiety symptoms and
depressive symptoms.
(d) The Sheehan Disability Scale (Sheehan, 1986)
is a simple measure of social functioning.
It assesses disruption to daily lifestyle and
comprises three 10-point subscales on which
patients self-rate disruption to work, social life,
and family or home life.
Procedure
Following initial assessment to establish diagno-
sis, inclusion/exclusion criteria, plus completion of
self-report and assessor measures, patients were
randomly allocated to EMDR, ‘exposure plus cog-
nitive restructuring’ E C CR or waiting list control
(WL). Randomization was by means of a predeter-
mined schedule unbeknown to the assessors, thera-
pists or patients. Following completion of the entire
initial assessment, for those patients who met entry
criteria, the blind assessor then opened a sealed
envelope that informed as to which group patients
were to be allocated. Our aim was to achieve cell
sizes of approximately 30 completers per group.
However, as the study progressed the drop-out
rate for both active treatment groups was consider-
ably higher than that of the WL and consequently
the randomization ratio was modified to increase
allocation to both EMDR and E C CR groups.
Some studies have suggested that very few ses-
sions of EMDR are necessary to achieve treatment
gains (e.g. Shapiro, 1989) while others have sug-
gested that between five and seven sessions of
EMDR are required (Boudewyns & Hyer, 1996)
and yet others set no limits to the number of EMDR
treatment sessions (Marcus et al., 1997). Since there
is no widely accepted agreement on the number
of EMDR treatment sessions required (Shapiro,
1995) it was thought appropriate for the present
study that the maximum number of treatment
sessions permitted be more in keeping with tra-
ditional brief psychotherapy (i.e. 10 sessions) and
with previous exposure-based studies for PTSD
(e.g. Keane et al., 1989). This rationale for deter-
mining the number of treatment sessions has been
proposed by Carlson et al. (1998). However, if as
argued in the literature, EMDR is highly effective
after only a few treatment sessions, then it would
be inappropriate to continue with further treat-
ment appointments following positive treatment
outcome. As a pragmatic compromise a maximum
number of treatment sessions were determined.
Active treatment groups received up to 10 weekly
sessions of 90 min duration. EMDR and E C CR
groups completed a mid-point assessment at week
5 with their respective therapists and at the end of
the 10-week study period completed a final blind
assessment. At end of waiting list period patients
were offered active treatment and therefore the WL
group was not assessed for post-study follow-up.
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Treatment
Treatment was conducted by one behavioural psy-
chotherapist who had considerable experience in
the treatment approaches offered and by one psy-
chiatric research registrar who, in relation to EMDR,
was trained specifically for the research study. Both
therapists had received Level I and II training in
EMDR by the EMDR Institute. Prior to EMDR
training, both therapists had considerable expe-
rience in exposure-based strategies, in particular
in relation to the Lovell model as used by Marks
et al. (1998). Each therapist provided both EMDR
and E C CR treatment. Treatment sessions were
conducted individually and both therapists were
supervised by a consultant psychiatrist. A selection
of treatment sessions were audio-taped to check for
treatment integrity.
EMDR
The eight essential phases of EMDR treatment
have been outlined in detail by Shapiro (1995).
In brief, incorporated within these components
are thorough screening of the patient’s present-
ing picture, including evaluation of dysfunctional
behaviours, symptoms and characteristics which
need to be addressed and identification of suit-
able targets for processing. Explanation of treat-
ment rationale and treatment plan entailed the
patient and therapist identifying a traumatic mem-
ory, formulating a negative belief statement about
the traumatic incident and identifying the sen-
sory responses thus aroused, including images,
beliefs, emotions and physiological correlates. The
patient’s attention is directed to an external stim-
ulus while he/she simultaneously concentrates
on an identified source of emotional disturbance.
External stimuli used included bilateral saccadic
eye movements or alternating hand taps. Feed-
back ratings, using subjective units of discomfort
(SUDS) were taken regularly. When distress had
sufficiently reduced on the part of the patient neg-
ative belief statements were replaced by preferred
belief statements and saccadic eye movements or
hand taps again induced. The reprocessing proce-
dure was repeated during each treatment session,
until the positive statement was rated as believable
by the patient. EMDR was structured in accor-
dance with the procedures outlined by Shapiro
(1995).
E C CR
Following detailed assessment of the patients’
presenting problem individuals were provided
with a treatment rationale containing information
about symptoms of PTSD and an explanation of
the relationship between thoughts, feelings and
behaviour. Intervention sessions initially took the
form of imaginal exposure which were audio-taped.
Therapists facilitated this process by prompting,
questioning and encouraging. Patients were pro-
vided with audio-tape copies and asked to listen
to the recording at least once per day as home-
work. This replicates procedures used by Foa et al.
(1991). Latter sessions incorporated in vivo exposure
where appropriate, plus evaluation and modifica-
tion of negative thoughts, underlying assumptions
and beliefs related to the trauma. E C CR was
structured in accordance with a treatment man-
ual for exposure and cognitive restructuring for
post-traumatic stress disorder as devised by Lovell
(personal communication) and used by Marks et al.
(1998).
WL
Subjects were informed that they would receive
treatment at the end of the waiting list period,
when they would be randomly allocated to either
EMDR or E C CR. WL patients were provided with
a contact telephone number in case of any dete-
rioration or impairment in their overall condition
which necessitated urgent and/or immediate ther-
apeutic intervention, however no patient availed
themselves of this service.
RESULTS
Of those referred, four failed to attend for initial
screening. Of those who attended initial screening,
two failed to meet PTSD criteria, two had recently
received psychological treatment for PTSD, three
had concurrent psychiatric or physical illness or
major social problems, and two refused consent.
A total of 105 patients met entry criteria and were
randomized to groups as follows: 39 to EMDR, 37
to E C CR and 29 to WL. Drop-out rates between
these three groups were as follows, 12 (31%) from
EMDR, 16 (43%) from E C CR and five (17%) from
WL 2 D 5.6, df D 2, p D 0.06. When comparison
was made between the two active treatments alone,
of those allocated to EMDR, five dropped out after
initial assessment and prior to commencement
of treatment, while seven dropped out following
commencement of treatment and failed to attend
mid-point assessment. Of those allocated to E C CR,
six dropped out after initial assessment and prior to
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commencement of treatment, while 10 dropped out
following commencement of treatment and failed
to attend mid-point assessment. No differences
existed between EMDR and E C CR groups in the
drop-out rates after initial assessment but prior
to commencement of treatment 2 D 0.6, df D 1,
p D 0.44, or following initiation of treatment but
prior to mid-point assessment 2 D 1.5, df D 1,
p D 0.22.
Comparison between the 33 drop-outs and the 72
completers regarding presentation at time of ini-
tial assessment produced no significant differences
on any of the demographic characteristics or treat-
ment outcome measures with the sole exception of
a higher frequency score on the CAPS-C Avoid-
ance subscale for the drop-outs t D 2.2, df D 103,
p < 0.05.
Subsequent analysis was conducted on the
72 completers. One-way analysis of variance
(ANOVA) revealed no significant differences
between groups on any of the pre-treatment depen-
dent variables such as severity of PTSD symp-
toms, and other measures of psychopathology,
whether assessor rated or self-rated. Similarly,
as illustrated in Table 1 there were no differ-
ences between groups with regard to age, length
of time since initial trauma, gender, marital sta-
tus, history of previous psychiatric illness, type
of trauma, or prescribed psychotropic medication
at time of inclusion in the study. However, it is
noteworthy that, for the entire subject group, pre-
scribed psychotropic medication rose from 5.5%
at time of trauma to 72.2% at time of inclu-
sion in the study.
Table 1. Demographic characteristics by treatment group
Variable EMDR E C CR WL Comparison
n D 27 n D 21 n D 24
Age (SD) 38.6 43.2 36.5 F D 2.0, df D 2, n.s.
(11.8) (11.0) (11.6)
Time since trauma (weeks (SD)) 180.0 155.4 259.5 F D .56, df D 2, n.s.
(321.4) (286.9) (426.0)
Gender
Male 15 13 14 2 D 0.2, df D 2, n.s.
Female 12 8 10
Marital status
Married 20 11 14 2 D 7.3, df D 6 n.s.
Single 4 4 7
Sep/Wid/Div. 3 6 2
Previous psychiatric history
Yes 10 4 6 2 D 2.0, df D 2 n.s.
No 17 17 17
Type of trauma
Vehicular passenger 7 5 5 2 D 15.7, df D 14, n.s.
Pedestrian 1 1 3
Occupational accident 2 5 9
Physical assault 4 5 4
Sexual assault 2 1 0
Traumatic death 3 0 0
Real/implied 4 3 2
physical threat
Other 4 1 0
Psychotropic medication
At time of trauma
Yes 2 0 2 2 D 2.7, df D 4 n.s.
No 24 21 21
Unknown 1 0 1
At time of study
Yes 19 17 16 2 D 1.2, df D 2, n.s.
No 8 4 8
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Treatment Effects
Analyses were conducted in three separate stages.
Because WL were only assessed at two points
in time, the first set of analyses involves a
series of 2 ð 3 ANOVAS, Time (pre-treatment,
post-treatment) ð Group (EMDR, E C CR, WL)
with time as the repeated measure. These results
provide an indication of ‘Treatment Outcome’.
Since it has been claimed that EMDR produces
significant treatment gains with fewer appoint-
ments and clinical improvement at an earlier stage
than conventional exposure treatments, the sec-
ond set of analyses involves a series of 2 ð 2
ANOVAs, Time (pre-treatment, mid-treatment) ð
Group (EMDR, E C CR) with time as the repeated
measure. These results provide an indication of
any differences in ‘Treatment Response Rapidity’
between EMDR and E C CR.
The third set of analyses involves assessment
of the level of any treatment gains maintained
at follow-up. Since the WL group were offered
treatment after the waiting list period had elapsed,
follow-up results are only presented for the EMDR
and E C CR groups.
In a similar manner to that outlined by Foa et al.
(1991) correlational analyses were conducted on the
outcome measures pre-, mid- and post-treatment.
As regards the self-assessment measures, SI-PTSD
total, avoidance, re-experiencing and arousal were
moderately to highly correlated (range 0.22 to 0.97)
at different assessment times. Likewise, IOE total,
intrusion and avoidance (range 0.21 to 0.93). A
wide range of correlations between SI-PTSD and
HADS Anxiety and Depression (range 0.35 to
0.91) and between IOE and HADS Anxiety and
Depression (range 0.15 to 0.93) were also evident.
For the respective assessor rating measures similar
correlation ranges existed. Thus because of the
wide range of intercorrelations between dependent
variables, separate ANOVAs were conducted for
each variable. This is also in keeping with the
procedure adopted by Marks et al. (1998) who also
argues that use of separate ANOVAs instead of a
MANOVA facilitates comparison between studies.
Treatment Outcome: Self-Report Measures
Table 2 illustrates means and standard devia-
tions for all three treatment groups pre- and
post-treatment on all patient self-report measures.
Table 3 illustrates the results of a series of 2 ð 3
ANOVAs Time (pre-treatment, post-treatment) ð
Group (EMDR, E C CR, WL) with time as the
repeated measure plus post-hoc Scheffe compar-
isons. A consistent pattern of results emerge.
IOE Scale
For the IOE total, significant time p < 0.001,
interaction p < 0.001 and group p < 0.001 effects
emerged with post-hoc Scheffe tests revealing
end-point difference between EMDR versus WL
p < 0.001 and E C CR versus WL p < 0.05.
No significant differences between EMDR versus
E C CR were evident. Pairwise comparison of pre-
and post-changes indicated significant reductions
in IOE Total for EMDR t D 9.5, p < 0.001 and
E C CR t D 5.1, p < 0.001 but no change in WL
t D 1.9, p D 0.07.
IOE Intrusion subscale produced significant
time p < 0.001, interaction p < 0.001 and group
p < 0.05 effects with post-hoc Scheffe tests reveal-
ing end-point differences between EMDR versus
WL p < 0.05. No significant differences between
EMDR versus E C CR were shown. Pairwise com-
parison of pre- and post- changes indicated signif-
icant reductions in IOE intrusion scores for EMDR
t D 9.0, p < 0.001 and E C CR t D 7.7, p < 0.001
but no change in WL t D 1.1, p D 0.27.
IOE Avoidance subscale similarly produced sig-
nificant time p < 0.001, interaction p < 0.001
and group p < 0.001 effects with post-hoc end-
point differences between EMDR versus WL p <
0.001. No differences between E C CR versus WL
or between EMDR versus E C CR were appar-
ent. Comparison of pre- post- changes showed
reductions in IOE Avoidance scores for EMDR
t D 8.8, p < 0.001, E C CR t D 3.2, p < 0.05 and
WL t D 2.2, p < 0.05.
SI-PTSD Scale
The SI-PTSD Total revealed significant time
p < 0.001, interaction p < 0.001 and group
p < 0.001 effects with post-hoc Scheffe compar-
isons revealing end-point differences between
EMDR versus WL p < 0.001, and E C CR ver-
sus WL p < 0.01. No differences between EMDR
versus E C CR occurred. Pairwise comparison
indicated pre–post reductions for EMDR t D
10.0, p < 0.001 and E C CR t D 5.0, p < 0.001
groups alone.
SI-PTSD Re-experience subscale produced signif-
icant time p < 0.001, interaction p < 0.001 and
group p < 0.05 effects. Avoidance and Arousal
subscales both produced significant time (all p <
0.001) interaction (all p < 0.001) and group (all
p < 0.001) effects. For the SI-PTSD Re-experience
subscale, post-hoc end-point difference between
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Table 2. Means and (SDs) of self-report measures by EMDR n D 27, E C CR
(n D 21) and WL n D 24 groups at pre-, mid-, post-treatment
Variable Pre- Mid- Post-
IOE total
EMDR 35.1 (4.4) 24.0 (8.7) 11.8 (12.0)
E C CR 32.7 (5.0) 29.1 (9.2) 19.2 (12.3)
WL 32.6 (6.6) — 29.6 (8.6)
IOE Intrusion
EMDR 17.8 (3.0) 13.7 (5.1) 6.2 (6.6)
E C CR 15.8 (3.7) 14.6 (5.3) 8.5 (5.7)
WL 15.4 (4.4) — 14.3 (5.2)
IOE Avoidance
EMDR 17.3 (2.6) 10.3 (4.8) 6.0 (6.1)
E C CR 16.9 (3.5) 14.7 (4.6) 10.7 (7.7)
WL 17.3 (3.5) — 15.3 (5.1)
SI-PTSD Total
EMDR 50.6 (8.4) 33.4 (14.0) 16.8 (17.2)
E C CR 46.6 (9.9) 41.4 (15.0) 25.9 (17.9)
WL 47.9 (10.0) — 45.5 (16.1)
SI-PTSD Re-experience
EMDR 12.2 (3.1) 8.6 (4.5) 3.7 (4.8)
E C CR 11.2 (3.0) 10.8 (4.3) 5.4 (4.8)
WL 10.9 (3.7) — 9.7 (4.3)
SI-PTSD Avoidance
EMDR 19.6 (4.3) 11.6 (5.6) 5.7 (6.6)
E C CR 16.7 (6.5) 16.0 (7.5) 10.2 (8.0)
WL 18.3 (4.50) — 17.8 (7.5)
SI-PTSD Arousal
EMDR 18.6 (3.6) 13.2 (4.7) 7.5 (6.5)
E C CR 17.5 (3.6) 15.0 (5.8) 10.3 (6.8)
WL 18.2 (4.5) — 17.5 (5.9)
HADS Anxiety
EMDR 15.3 (3.0) 12.4 (3.9) 7.7 (5.1)
E C CR 13.5 (2.9) 12.5 (3.3) 9.6 (5.0)
WL 15.4 (3.9) — 14.2 (4.6)
HADS Depression
EMDR 11.2 (3.4) 8.9 (4.0) 4.0 (5.0)
E C CR 11.3 (3.7) 10.0 (5.4) 8.6 (5.8)
WL 12.7 (4.5) — 12.8 (5.6)
Sheehan Total
EMDR 21.3 (5.4) 20.6 (6.9) 9.2 (10.9)
E C CR 22.8 (6.3) 19.2 (7.7) 15.7 (10.5)
WL 23.3 (4.7) — 21.7 (6.4)
EMDR versus WL p < 0.05 occurred with no
E C CR versus WL or EMDR versus E C CR
differences. Pairwise comparisons for the SI-PTSD
Re-experience subscale revealed reductions for the
EMDR t D 8.9, p < 0.001 and E C CR t D 6.3, p <
0.001 groups alone.
On the SI-PTSD Avoidance subscale post-hoc
end-point differences for EMDR versus WL p <
0.001 and E C CR versus WL p < 0.05 again
emerged with no EMDR versus E C CR difference.
Pairwise comparisons for the SI-PTSD Avoidance
subscale showed a reduction for the EMDR t D 9.4,
p < 0.001 and E C CR t D 2.9, p < 0.05 groups
alone.
The SI-PTSD Arousal subscale produced post-
hoc differences for EMDR versus WL p < 0.001
and E C CR versus WL p < 0.05 again with
no EMDR versus E C CR differences. Pre–post
pairwise SI-PTSD Arousal subscale comparisons
produced significant reductions for the EMDR
t D 8.1, p < 0.001 and E C CR t D 4.9, p < 0.001
groups alone.
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Table 3. Analyses of variance of time (pre-treatment, post-treatment) ð group (EMDR, E C CR, WL) for self-report
measures with post-hoc Scheffe tests
Variable Time Time ð group Group Scheffe
(df 1,71) (df 2,71) (df 2,71)
F p < F p < F p <
IOE Total 101.3 0.000 21.2 0.000 8.8 0.000 1–3ŁŁŁ, 2–3*
IOE Intrusion 106.3 0.000 23.7 0.000 3.8 0.05 1–3Ł
IOE Avoidance 66.3 0.000 12.8 0.000 11.6 0.000 1–3ŁŁŁ
SI-PTSD Total 90.7 0.000 18.0 0.000 9.8 0.000 1–3ŁŁŁ, 2–3ŁŁ
SI-PTSD Re-experience 94.8 0.000 18.0 0.000 3.5 0.000 1–3Ł
SI-PTSD Avoidance 53.0 0.000 17.8 0.000 8.9 0.000 1–3ŁŁŁ, 2–3Ł
SI-PTSD Arousal 75.0 0.000 18.8 0.000 8.6 0.000 1–3ŁŁŁ, 2–3Ł
HADS Anxiety 68.8 0.000 14.4 0.000 9.4 0.005 1–3ŁŁ, 2–3Ł
HADS Depression 41.6 0.000 18.4 0.000 9.3 0.000 1–3ŁŁŁ
Sheehan Total 48.4 0.000 9.8 0.000 7.9 0.001 1–3ŁŁŁ
Ł p < 0.05; ŁŁ p < 0.01; ŁŁŁ p < 0.001.
Post-hoc Scheffe treatment group comparisons: 1 D EMDR, 2 D E C CR, 3 D WL.
Groups separated by a hyphen differ significantly from each other.
HADS
A similar pattern of results to that shown by IOE
and SI-PTSD scores emerged for the HADS-Anxiety
scores with significant time p < 0.001, interaction
p < 0.001 and group effects p < 0.005, and
post-hoc difference between EMDR versus WL
p < 0.001 and E C CR versus WL p < 0.05 alone.
Here again, comparisons between EMDR versus
E C CR were not significant. Similarly pre–post
reductions on HADS-Anxiety occurred for EMDR
t D 8.3, p < 0.001, and E C CR t D 4.0, p < 0.001
groups alone.
The HADS Depression scores produced signifi-
cant time p < 0.001, interaction p < 0.001 and
group p < 0.001 effects with post-hoc Scheffe tests
revealing end-point differences between EMDR
versus WL p < 0.001 alone. Pre–post pairwise
comparisons on HADS Depression occurred for
EMDR t D 8.0, p < 0.001 and E C CR t D 2.8, p <
0.05 groups alone.
Sheehan Disability Scale
Disruption to work, social life and family/home
life caused by PTSD symptoms was reflected in
the Sheehan Total scores which revealed significant
time p < 0.001, interaction p < 0.001 and group
p < 0.001 effects. The only post-hoc Scheffe test
to achieve significance was between EMDR versus
WL p < 0.001 with less disruption apparent in the
EMDR group. No difference between EMDR and
E C CR emerged. Pre–post pairwise comparisons
revealed significant reductions in Sheehan Total
scores for EMDR t D 7.1, p < 0.001 and E C CR
t D 3.1, p < 0.05 groups.
Treatment Outcome: Assessor-Rated Measures
Table 4 presents means and standard deviations
for all three treatment groups pre- and post-
treatment on the MADRS and HAM-A. CAPS
assessments were not routinely collected on all
control group subjects at end of WL period and
therefore only the pre-treatment CAPS scores are
presented for this group.
Table 5 illustrates the results of 2 ð 3
ANOVAs, Time (pre-treatment, post-treatment) ð
Group (EMDR, E C CR, WL) for MADRS and
HAM-A scores. Table 6 gives the results of 2 ð 2
ANOVAs, Time (pre-treatment, post-treatment) ð
Group (EMDR, E C CR) for CAPS scores.
MADRS
With regard to MADRS scores a significant
time p < 0.001, interaction p < 0.001 and group
effect p < 0.001 and group effect p < 0.001
emerged with post-hoc Scheffe tests producing
differences between EMDR versus WL p < 0.001
and E C CR versus WL p < 0.001. No difference
between EMDR and E C CR existed. Pre–post
pairwise comparisons showed significant reduction
in depression scores for EMDR t D 8.8, p < 0.001
and E C CR t D 4.6, p < 0.001 but not WL t D
0.7, p D 0.5.
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Table 4. Means and (SDs) of assessor-rated measures by EMDR n D 27,
E C CR n D 21 and WL n D 24 groups at pre-, mid- and post-treatment
Variable Pre- Mid- Post-
MADRS
EMDR 26.4 (5.5) 20.8 (6.6) 9.3 (10.1)
E C CR 24.6 (7.8) 23.5 (8.1) 14.8 (9.2)
WL 27.7 (7.9) — 26.4 (11.7)
HAM-A
EMDR 26.2 (6.4) 19.6 (4.8) 9.1 (8.4)
E C CR 24.9 (8.0) 22.9 (8.7) 13.1 (9.0)
WL 26.7 (8.1) — 23.3 (11.3)
CAPS-B (Re-exp). Freq
EMDR 10.2 (2.8) — 2.0 (2.8)
E C CR 10.0 (4.0) — 3.2 (2.7)
WL 9.4 (3.9) — —
CAPS-B (Re-exp). Int.
EMDR 10.6 (2.9) — 2.0 (2.6)
E C CR 10.5 (3.7) — 3.8 (3.4)
WL 9.7 (3.9) — —
CAPS-C (Avoid) Freq.
EMDR 16.0 (3.7) — 3.5 (5.2)
E C CR 15.9 (4.5) — 6.8 (5.1)
WL 15.6 (4.7) — —
CAPS-C (Avoid) Int.
EMDR 15.9 (3.9) — 3.2 (4.5)
E C CR 15.7 (4.4) — 6.3 (5.0)
WL 15.3 (4.2) — —
CAPS-D (Arousal) Freq.
EMDR 17.0 (3.3) — 5.0 (5.0)
E C CR 16.7 (3.4) — 6.8 (4.4)
WL 16.9 (3.4) — —
CAPS-D (Arousal) Int.
EMDR 15.8 (2.8) — 4.9 (4.5)
E C CR 15.7 (3.0) — 7.1 (4.6)
WL 15.8 (2.7) — —
Table 5. Analyses of variance of time (pre-treatment, post-treatment) ð group (EMDR,
E C CR, WL) for assessor-rated measures with post-hoc Scheffe tests
Variable Time Time ð group Group Scheffe
(df 1,71) (df 2,71) (df 2,71)
F p < F p < F p <
MADRS 69.2 0.000 17.4 0.000 10.4 0.000 1.3ŁŁŁ, 2–3ŁŁ
HAM-A 94.5 0.000 13.6 0.000 7.3 0.001 1–3ŁŁ, 2–3Ł
Ł p < 0.05; ŁŁ p < 0.01; ŁŁŁ p < 0.001.
Post-hoc Scheffe treatment group comparisons: 1 D EMDR, 2 D E C CR, 3 D WL.
Groups separated by a hyphen differ significantly from each other.
HAM-A
A significant time p < 0.001, interaction p <
0.001 and group p < 0.001 effect existed in
relation to HAM-A scores with post-hoc Scheffe
tests showing differences between EMDR ver-
sus WL p < 0.001 and E C CR versus WL p <
0.05, but no difference between EMDR and
E C CR. Pre–post pairwise comparisons indicated
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Table 6. Analyses of variance of time (pre-treatment, post-treatment) ð group
(EMDR, E C CR) for assessor-rated measures
Variable Time Time ð Group Group
(df 1,71) (df 1,72) (df 1,72)
F p < F p < F p <
CAPS-B (Re-exp). Freq 179.6 0.000 1.5 n.s. 0.4 n.s.
CAPS-B (Re-exp). Int. 184.5 0.000 3.9 n.s. 1.2 n.s.
CAPS-C (Avoid) Freq. 147.8 0.000 4.3 0.05 1.7 n.s.
CAPS-C (Avoid) Int. 178.4 0.000 4.5 0.05 1.5 n.s.
CAPS-D (Arousal) Freq. 251.4 0.000 2.7 n.s. 0.5 n.s.
CAPS-D (Arousal) Int. 217.1 0.000 2.8 n.s. 1.2 n.s.
CAPS Soc. Functioning 75.4 0.000 10.0 0.05 1.7 n.s.
significant reductions in anxiety scores for EMDR
t D 8.9, p < 0.001 and E C CR t D 5.7, p < 0.001
but not WL t D 1.9, p D 0.06.
CAPS
Significant changes across time occurred for both
EMDR and E C CR groups with regard to both
a reduction in the frequency and intensity of re-
experiencing/intrusive symptoms, avoidance and
hyperarousal (all p < 0.001). Only three interaction
effects all p < 0.05 occurred in relation to the
frequency of avoidance symptoms, the intensity
of re-experiencing/intrusive symptoms and social
functioning. There were no between group dif-
ferences for EMDR versus E C CR in relation to
re-experiencing/intrusion, avoidance and hyper-
arousal. For both EMDR and E C CR pre–post
pairwise comparisons revealed significant reduc-
tions in all of these PTSD symptom measures (all
p < 0.001).
On the basis of the above, EMDR is consistently
superior to WL on all the aforementioned outcome
measures. A slightly different pattern of results
exists whereby E C CR is superior to WL only
on a subset of outcome measures. Despite this,
no significant differences between EMDR versus
E C CR emerged. Effect sizes (ES) were therefore
calculated by subtracting the mean of the post-
treatment control group from the post-treatment
experimental groups and then dividing by the
standard deviation of the control group at post-
treatment (Glass, McGraw, & Smith, 1981). On all
outcome measures, including each of the subscales
the ES pre–post change was greater for the EMDR
than for the E C CR group. For example, on IOE
Total (2.1 vs. 1.2), SI-PTSD Total (1.8 vs. 1.2), HADS
anxiety (1.4 vs. 1.0), HADS depression (1.6 vs. 0.8),
Sheehan Total (1.9 vs. 0.9), MADRS (1.5 vs. 1.0),
and HAM-A (1.3 vs. 0.9) for EMDR versus E C CR
groups respectively.
Treatment Outcome: Clinical Significance
The foregoing results are described entirely in terms
of the statistical significance of change in treatment.
It has been argued (Jacobson & Ravenstorf, 1988;
Jacobson & Truax, 1991) that statistically significant
results may nonetheless have little clinical signifi-
cance. Jacobson and colleagues argued for further
analysis of outcome data in terms of the clinical
significance of change and suggested criteria for
assessment. Lindsay, Gamsu, McLaughlin, Hood
and Espie (1987) stated that the most stringent
of these is to assess whether a patient’s outcome
response falls outside the range of the dysfunc-
tional population by two standard deviations from
the pre-treatment mean of that population in the
direction of functionality. Tables 7a and 7b illustrate
the number of patients achieving these criteria at
the end of the treatment period. Table 7a illustrates
significant differences on all measures that compare
EMDR versus E C CR versus WL with the majority
of WL patients failing to show clinically signifi-
cant change. Comparison between EMDR versus
E C CR indicates no differences in the proportion
of patients achieving clinically significant change
on measures of PTSD symptomatology such as the
IOE Total, IOE Intrusion, IOE Avoidance, SI-PTSD
Total, SI-PTSD Re-experiencing, SI-PTSD Avoid-
ance and SI-PTSD Arousal. On many of these
measures approximately 60% of the EMDR and
50% of the E C CR groups achieved clinically sig-
nificant change in comparison with less than 10%
of the WL group. Thus EMDR and E C CR appear
equally clinically effective on measures of self-rated
PTSD symptomatology in comparison with WL.
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Table 7a. Number and (%) of patients in each group who do or do not achieve clinically significant change at
end-point comparing (a) EMDR versus E C CR and (b) EMDR versus E C CR versus WL
Variable EMDR E C CR 2 p < WL 2 p <
n D 27 n D 21 df D 1 n D 24 df D 1
Yes No Yes No Yes No
IOE total 17 10 9 12 1.9 n.s. 1 23 19.1 0.000
(63) (37) (43) (57) (4) (96)
IOE Intrusion 18 9 10 11 1.8 n.s. 2 22 18.2 0.000
(67) (33) (48) (52) (8) (92)
IOE Avoidance 19 8 10 11 2.6 n.s. 2 22 20.2 0.000
(70) (30) (48) (52) (8) (92)
SI-PTSD total 18 9 11 9 1.0 n.s. 1 23 21.8 0.000
(67) (33) (52) (48) (4) (96)
SI-PTSD 22 5 12 8 2.6 n.s. 8 16 12.2 0.05
Re-experience (81) (19) (60) (40) (33) (67)
SI-PTSD 20 7 12 8 1.0 n.s. 6 18 12.8 0.05
Avoidance (74) (26) (60) (40) (25) (75)
SI-PTSD 16 11 7 13 2.7 n.s. 1 23 17.3 0.000
Arousal (59) (41) (35) (65) (4) (96)
HADS 13 14 7 14 1.1 n.s. 3 24 7.5 0.05
Anxiety (48) (52) (33) (67) (13) (87)
HADS 22 5 9 12 7.7 0.05 4 20 21.8 0.000
Depression (81) (19) (43) (57) (17) (83)
Sheehan 19 8 8 13 5.0 0.05 2 22 20.4 0.000
Disability (70) (30) (38) (62) (8) (92)
MADRS 21 6 11 10 3.4 n.s. 4 20 19.0 0.000
(78) (22) (52) (48) (17) (83)
HAM-A 22 5 13 8 2.3 n.s. 5 19 19.4 0.000
(82) (18) (62) (38) (21) (79)
Table 7b. Number and (%) of patients in each group (EMDR versus E C CR) who do or
do not achieve clinically significant change at end-point
Variable EMDR E C CR 2df D 1 p <
n D 25 n D 19
Yes No Yes No
CAPS-B (Re-exp). Freq 23 2 18 1 0.1 n.s.
(92) (8) (95) (5)
CAPS-B (Re-exp). Int. 23 2 14 5 2.7 n.s.
(92) (8) (74) (26)
CAPS-C (Avoid) Freq. 22 3 12 7 3.8 n.s.
(88) (12) (63) (37)
CAPS-C (Avoid) Int. 22 3 15 4 0.7 n.s.
(88) (12) (79) (21)
CAPS-D (Arousal) Freq. 18 7 11 8 1.0 n.s.
(72) (28) (58) (42)
CAPS-D (Arousal) Int. 16 9 8 11 2.1 n.s.
(64) (36) (42) (58)
Table 7b similarly illustrates no differences
between EMDR versus E C CR groups as
regards the proportion of patients achieving
clinically significant change as measured by the
assessor-rated CAPS score. In relation to the
EMDR group on the various CAPS subscales
between approximately 60 and 90% indicated
substantial clinical improvement in comparison
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to approximately 45 to 90% of E C CR patients.
Thus on both self-report and assessor-rated PTSD
measures significant clinical gains are achieved at
end of the treatment period for both EMDR and
E C CR groups.
In relation to measures of anxiety, both the
self-report HADS Anxiety and the assessor-rated
HAM-A produced significant differences in the
proportions of patients achieving clinical change
when comparisons are made between EMDR
versus E C CR versus WL. However, this is largely
due to approximately 85% of WL patients failing
to show any clinically significant change on such
measures whereas 62% of E C CR and 82% of
EMDR patients achieve such status on the HAM-A,
although fewer appear to do so on the HADS-
Anxiety (48 and 33% for EMDR and E C CR groups
respectively). Nevertheless no differences between
the two active treatment groups were apparent on
these anxiety measures at treatment outcome.
As regards depression, only 17% of the WL
group indicated substantial clinical change, and
significant differences between all three groups
emerged on the self-report HADS Depression and
the assessor-rated MADRS. However with refer-
ence to the two measures of depression it is only
on one of these measures that significant dif-
ferences between EMDR and E C CR occurred.
On the HADS Depression scale 81% of EMDR
patients in comparison with 43% of E C CR patients
achieved clinically significant reduction in symp-
toms p < 0.05. On the MADRS 78% of EMDR
patients and 52% of E C CR patients achieved this
status (n.s.). The only other measure that differ-
entiated between the EMDR and E C CR groups
was the Sheehan Disability Scale with 70 versus
38% respectively, having achieved clinically signif-
icant change.
Treatment Response Rapidity
In order to assess whether EMDR, in comparison
to E C CR, produced significant treatment gains
with fewer appointments and clinical improve-
ment at an earlier stage, a second set of analy-
ses comprising a series of 2 ð 2 ANOVAs, Time
(pre-treatment, mid-treatment) ð Group (EMDR,
E C CR) with time as the repeated measure were
undertaken. All of the aforementioned self-report
and assessor-rated measures were examined. Sig-
nificant time effects were produced on many of the
measures with modest interaction effects on fewer
measures. There were no group effects on any of the
measures and no differences between EMDR and
E C CR at mid-point. However, the mean number
of treatment sessions did differ by group, with the
EMDR group receiving a mean of 4.2 SD D 2.5
sessions in comparison to mean 6.4 SD D 3.2 for
the E C CR group (t D 2.7, df 46, p < 0.05).
Follow-Up Results
EMDR and E C CR patients were re-assessed, on
average at 15 months follow-up. Of the 27 EMDR
completers, five failed to attend, and 22 attended.
Of the 21 E C CR completers four failed to attend,
and 17 attended. Follow-up results are presented
here for the 22 EMDR and 17 E C CR follow-
ups. Table 8 illustrates the proportion of follow-up
patients who maintain clinically significant levels
of change. Comparison between EMDR and E C CR
groups indicates no difference in the proportion of
patients maintaining levels of clinically significant
change on all measures for PTSD symptomatology,
anxiety, and social functioning. The initial clini-
cally significant advantage of EMDR over E C CR
at end-point on the HADS Depression and Shee-
han Disability Scale appears to have disappeared
at follow-up. At follow-up the only apparent dif-
ference between EMDR and E C CR groups was
in respect to MADRS scores with 73% of EMDR
versus 35% of E C CR groups achieving clinically
significant change. Overall it appears that end-point
treatment gains appear to have been relatively well
maintained at follow-up for both groups, on virtu-
ally all measures.
Presentation of follow-up results in the above
manner may however provide an over-optimistic
picture of long-term treatment gains. It has been
argued that by reporting treatment maintenance
gains only in relation to follow-up attendees the
issue of patients requiring subsequent treatment
between the end of the study period and the
designated follow-up is not adequately addressed
(Power et al., 1990; Sharp et al., 1996). To circumvent
this difficulty collation of ‘unobtrusive measures’
at follow-up has been recommended (Bellack &
Hersen, 1984). Table 9 illustrates the number of
EMDR and E C CR patients who received psy-
chological or psychiatric referral or psychotropic
medication during the follow-up period. There was
no difference between groups in the proportion
of patients who received subsequent treatment
2 D 1.10, df D 1, p D 0.26. Given the confound-
ing influence of post-study treatment on status
at follow-up, Table 10 also presents clinically sig-
nificant results for those who are treatment free
post-study.
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Table 8. Number and (%) of follow-up patients who do or do not achieve clinically significant
change for EMDR and E C CR treatment groups
Number of follow-up attenders EMDR n D 22 E C CR n D 17 2 (df=1) p <
Yes No Yes No
IOE Total 10 12 6 11 0.4 n.s.
(45) (55) (35) (65)
IOE Intrusion 13 9 9 8 0.1 n.s.
(59) (41) (53) (47)
IOE Avoidance 11 11 6 11 0.8 n.s.
(50) (50) (35) (65)
SI-PTSD Total 12 9 7 10 1.0 n.s.
(57) (43) (41) (41)
SI-PTSD Re-experience 17 4 9 8 3.4 n.s.
(81) (19) (53) (47)
SI-PTSD Avoidance 15 6 8 9 2.3 n.s.
(71) (29) (47) (53)
SI-PTSD Arousal 12 9 5 12 2.9 n.s.
(57) (43) (29) (71)
HADS Anxiety 10 12 5 12 1.0 n.s.
(46) (54) (29) (71)
HADS Depression 16 6 9 8 1.6 n.s.
(73) (27) (53) (47)
Sheehan Disability 15 7 7 9 2.3 n.s.
(68) (32) (44) (56)
MADRS 16 6 6 11 5.5 0.05
(73) (27) (35) (65)
H AM-A 18 4 11 6 1.5 n.s.
(82) (18) (65) (35)
Table 9. Number and (%) of patients attending follow-up receiving
post-study psychological, psychiatric, psychotropic treatment
EMDR E C CR 2, pdf D 1
Nos of follow-up attenders n D 22 n D 17
Nos with
psychological/psychiatric
referral/psychotropic
medication
8 (36) 9 (53) —
Nos with no post-study
treatment
14 (64) 8 (37) 1.1 (n.s.)
Comparison between EMDR and E C CR again
indicates no difference in the proportion of patients
maintaining levels of clinically significant change
without subsequent treatment during the follow-up
period. Overall, the proportion of patients achiev-
ing clinically significant change in each group
is considerably reduced due to the exclusion of
patients who received intervening treatment and
those who failed to attend. A consistent pattern is
observable, however, in that for both EMDR and
E C CR groups, on measures of PTSD symptoma-
tology, anxiety, depression and social functioning,
only about 25–50% of patients maintain treatment
gains without additional post-study intervention.
It therefore appears that, in this study, regard-
less of the type of treatment offered, the majority
of patients, on most measures, do not achieve
clinically significant long-term follow-up gains
without additional psychological, psychiatric, or
psychotropic treatment.
In addition, the PTSD patient group under
study exhibited high levels of patient-generated GP
consultations with an average, over the 6 months
prior to treatment of 8.0 (SD 7.4) appointments for
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Table 10. Number and (%) of patients with no subsequent post-study treatment who achieve
clinically significant change at follow-up assessment (‘Yes’) versus those who do not achieve
post-study clinically significant change and/or have post-study treatment (‘No’)
Variable EMDR n D 22 E C CR (n D 17) 2 (df D 1) p <
Yes No Yes No
IOE total 7 15 4 13 0.3 n.s.
(32) (68) (23) (77)
IOE Intrusion 9 13 5 12 0.6 n.s.
(41) (59) (29) (71)
IOE Avoidance 7 15 4 13 0.3 n.s.
(32) (68) (23) (77)
SI-PTSD Total 9 12 5 12 0.7 n.s.
(43) (57) (29) (71)
SI-PTSD Re-experience 12 9 5 12 2.9 n.s.
(57) (43) (29) (71)
SI-PTSD Avoidance 10 11 5 12 1.3 n.s.
(48) (52) (29) (71)
SI-PTSD Arousal 8 13 3 14 1.9 n.s.
(38) (62) (18) (82)
HADS Anxiety 7 15 3 14 0.05 n.s.
(32) (68) (18) (82)
HADS Depression 12 10 5 12 2.5 n.s.
(55) (45) (29) (71)
Sheehan Disability 11 11 4 13 2.4 n.s.
(50) (50) (23) (77)
MADRS 11 11 4 13 2.8 n.s.
(50) (50) (23) (77)
HAM-A 12 10 7 10 0.7 n.s.
(55) (45) (41) (59)
the EMDR group and 5.8 (SD 3.2) for the E C CR
group. No significant differences existed in the
frequency of patient-generated GP consultations
between groups either in the 6 months prior to
treatment or in the 6 months post-treatment, with
the frequency of consultations in the 6 months post-
treatment remaining high at an average of 5.0 (SD
4.4) for the EMDR group and 4.8 (SD 4.2) for the
E C CR group. However, comparison of the patient-
generated GP attendance rate for the two 6-month
periods (pre versus post) did indicate a reduction
for the EMDR group alone p < 0.05.
DISCUSSION
The present study attempted to compare EMDR
with its nearest rival, exposure plus cognitive
restructuring. In so doing a range of self-report
and assessor-rated measures were utilized to cover
the range of PTSD symptomatology and possible
co-morbid features of anxiety and depression.
Analysis of the data attempted to cover the issue of
change over treatment time and degree of clinically
significant change at end of the treatment phase
and at follow-up.
With regard to PTSD symptomatology an inter-
esting pattern of results emerged. EMDR and
E C CR were both effective in comparison to WL
on IOE Total, and on SI-PTSD Total, Avoidance
and Arousal scores. EMDR alone was effective in
comparison to WL on IOE Intrusion and Avoid-
ance and on SI-PTSD Re-experience. Furthermore
on CAPS Re-experience, Avoidance and Arousal
scores both EMDR and E C CR groups showed
equally significant treatment gains. On all of the
above measures there was no significant differ-
ence between experimental groups although ESs
for EMDR were consistently superior to that of
E C CR. Thus the superiority of EMDR over E C CR,
on measure of PTSD symptomatology, was pri-
marily shown in relation to WL comparisons with
less discernible differences occurring when direct
comparisons between experimental groups were
undertaken. In relation to PTSD, it has previously
been noted by Vaughan et al. (1994) that lack of
demonstrable superiority of any one treatment
over another may be due to small sample sizes in
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each condition, for example, number of subjects per
treatment 12 to 13 (Jensen, 1994); 11 to 13 (Vaughan
et al., 1994). However the present study had treat-
ment completer cell sizes of 21 to 27 which is at least
equivalent to those of Marks et al. (1998) who had
treatment completer cell sizes of 18 to 20 when com-
paring the efficacy of prolonged exposure versus
cognitive restructuring versus prolonged exposure
plus cognitive restructuring versus relaxation in
the treatment of PTSD. In addition Foa et al. (1991)
reported significant differences between stress inoc-
ulation training versus prolonged exposure versus
prolonged exposure versus supportive counselling
versus waiting list in the treatment of PTSD with
cell sizes of 10 to 14. One might therefore argue
that in the present study, the failure to find consis-
tent differences between EMDR versus E C CR on
measures of PTSD symptomatology is unlikely to
be attributable to inadequate cell size.
In relation to the remaining treatment outcome
measures it was only at the end of the treatment
phase, on measures of clinically significant change,
that differences between EMDR versus E C CR
emerged and here only on measures of self-reported
depression and social functioning. Imaginal and in
vivo exposure for PTSD has been shown to lead
to concurrent reductions in depression (Richards
et al., 1994) and EMDR has also been associated
with alleviation of depressive symptoms (Vaughan
et al., 1994). Given the speculative nature regarding
the theoretical basis of EMDR it is difficult to
explain why EMDR might be superior to E C CR
in reducing depression scores. In the present study
the majority of patients were receiving concurrent
medication, invariably antidepressants, but the
extent of prescription between groups did not
differ. However, the study used a large number
of treatment outcome measures thus increasing the
chance of significant between-group differences
occurring randomly. It is with this caveat that
results must be interpreted, additionally noting
the lack of significant differences between EMDR
and E C CR groups at follow-up on measures of
self-reported depression and social functioning.
Indeed, the only difference on measures of clinically
significant change at follow-up, in favour of EMDR
over E C CR, appeared in relation to assessor-rated
levels of depression.
Since Shapiro’s (1989) early claims of a 100% suc-
cess rate with a single EMDR treatment session,
there has been little agreement on the ‘appropri-
ate’ number of sessions with some authors offering
between five and seven (Boudewyns & Hyer, 1996).
While the present study offered a maximum of 10
treatment sessions the average number received for
EMDR was 4.2 and 6.4 for E C CR. This signifi-
cant difference in the number of treatment sessions
might be taken as an argument for the enhanced
cost-effectiveness of EMDR over exposure-based
treatments. However, it should also be noted
that E C CR was successfully practised with fewer
sessions than the 10 sessions offered by Marks
et al. (1998) or the 14 to 16 sessions utilized by
Keane et al. (1989). The present study therefore
suggests that EMDR requires considerably more
treatment sessions than initially suggested and
that exposure-based treatments may be effective
with considerably fewer sessions than routinely
expected. Unfortunately in the present study there
were no pre-determined and standardized criteria
by which treatment sessions were terminated fol-
lowing a ‘successful’ response. Rather the decision
not to offer further treatment following a positive
outcome was based on the clinical judgement of
the respective therapists. Thus arguments in favour
of superior cost-effectiveness of any one treatment
over another should be regarded cautiously.
Many studies have noted the high attrition rate
in PTSD studies, the exception being inpatient pro-
grammes (e.g. Boudewyns et al., 1990). The Marks
et al. (1998) study had a large number of PTSD-
diagnosed patients incorporated in a randomized
controlled trial. In this study 109 patients met
entry criteria, of whom 22 refused treatment and
10 dropped out, leaving a completers sample of
77 distributed between four treatment groups. Of
the 77 completers, 25 failed to complete 9 months
follow-up, many of whom were characterized by
high levels of depression at trial entry (Marks et al.,
1998). In the present study there was a significantly
larger proportion of EMDR and E C CR patients
who dropped out during treatment in comparison
to WL controls. The only feature that distinguished
drop-outs from completers was a higher frequency
score on the CAPS-C Avoidance subscale for those
who failed to complete treatment. It may there-
fore be that those with high levels of avoidance of
stimuli associated with the trauma are less likely
to tolerate treatment approaches, whether EMDR
or E C CR, that entail some degree of confrontation
with the traumatic image or situation. High drop-
out rates are a major problem of exposure-based
therapies, especially those that adopt sustained
exposure techniques. EMDR may be preferred by
patients since exposure comes in short bursts rather
than being sustained.
Although the present study consisted of a rel-
atively large sample of PTSD patients treated in
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a randomly controlled trial, the study also had
a high drop-out rate with 33 out of 105 patients
(30.4%) failing to complete the initial treatment
phase. Thus, exposure-based outpatient treatments
for a heterogeneous group of PTSD patients with a
wide variety of traumas may be less well tolerated
than suggested by some of the earlier studies that
incorporated arguably more homogeneous groups
such as inpatient Vietnam veterans.
Marcus et al. (1997) argued that EMDR was more
effective than standard care (which included a vari-
ety of psychotherapies, psychotropics and group
treatments) for the treatment of PTSD and con-
comitant anxiety and depression symptoms. On
the basis of such results these authors suggested
that EMDR might be effective for other anxiety
disorders and depression. However the present
study suggests that the alleviation of concomi-
tant anxiety and depressive symptoms in PTSD
is not unique to EMDR but can also be achieved by
E C CR. Foa et al. (1991) have also illustrated reduc-
tion in anxiety and depression scores in PTSD rape
victims when treated by stress inoculation train-
ing, prolonged exposure, supportive counselling,
or simply assessed and placed on a waiting list.
Foa et al. (1991) interpret such findings as suggest-
ing that ‘mere contact with a therapist is sufficient
to ameliorate non-specific distress’ (p. 722). Whilst
we would concur with such sentiments it is note-
worthy that in our research there were no marked
changes in the presenting profile of WL patients
as regards anxiety and depression. An alternative
explanation might be that effectively treating PTSD
symptoms leads to a concurrent reduction in anxi-
ety and depression scores over and above that due
to mere therapist contact and assessment alone.
When considering the findings of the present
study a number of methodological inadequacies
should be borne in mind. Not all assessments
were carried out by ‘blind’ assessors. However,
assessment at entry, end-point and follow-up were
conducted by ‘blind’ assessors. Only the mid-point
assessment was completed unblind. A consider-
able proportion of patients were on concurrent
psychotropic medication although this was equally
true for EMDR, E C CR and WL groups, the latter of
which failed to show any substantial improvement.
Thus improvements achieved by the EMDR and
E C CR groups are unlikely to be attributed solely
to pharmacological treatment. Unfortunately, the
study did not employ any biochemical assessments
of levels of prescribed psychotropics and it is there-
fore not possible to assess whether psychotropic
compliance affected the results. Pre-determined
standardized criteria of withdrawal due to treat-
ment efficacy prior to the maximum of 10 therapy
sessions was not adhered to. Rather, withdrawal
due to treatment efficacy, prior to the maximum
of 10 sessions was determined on a practical basis
when therapist and patient were both of the opinion
that further treatment gains were unlikely. There
was no formalized assessment of patient compli-
ance with between session exposure homework
requirements. Of the two therapists, one was more
experienced in EMDR than the other. Notwith-
standing such limitations, the present research has
attempted to improve upon the many methodolog-
ical inadequacies associated with many previous
studies in this field.
The use of strict criteria for follow-up clinical
significance, namely no prescribed psychotrop-
ics and/or referral to psychology or psychiatry,
served to reduce the apparent effectiveness of
both treatments. However, it has been argued that
this is preferable to the procedure wherein post-
study treatments are not given sufficient attention
(Sharp & Power, 1997). Follow-up results were
also affected by lack of information available for
patients who defaulted on follow-up appointments.
The question of maintenance of treatment gains is
of considerable clinical relevance given the high
level of co-morbidity among PTSD patients, the
current dearth of studies with long-term follow-
up data and the apparent heavy demands on
primary care resources both prior to and follow-
ing treatment. The considerable treatment gains,
initially achieved, appear to be well-maintained
at long-term follow-up, but a substantial propor-
tion of patients only maintain this level of clinical
improvement if additional psychological, psychi-
atric and/or psychotropic treatment is available.
For many of the patients presenting with PTSD
a high level of health service usage arises fol-
lowing the trauma and appears to continue after
treatment. In summary, the present study suggests
that both EMDR and E C CR are effective in the
treatment of PTSD, albeit with fewer EMDR treat-
ment sessions.
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